A recent study demonstrated that FPR3 inhibits the AKT/mTORC1 signaling pathway by modulating cellular calcium ion fluxes, thereby impeding the progression of gastric cancer (Wang et al., 2024). This evidence concerns the gene FPR3 and gastric cancer.